Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

News & Events
: Investor Presentations

Investor Presentations

Abbreviated

Uploaded: Jun 4, 2018
Type: Pdf

Corporate Presentation

Uploaded: Jun 4, 2018
Type: Pdf

Corporate Presentation - Short Version

Uploaded: Jun 4, 2018
Type: Pdf